Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shôn Lewis

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Schizophrenia Bulletin|March 12, 2015
The promise of biological markers for treatment response in first-episode psychosis: a systematic reviewGuillaume Fond, Marc-Antoine d'Albis, Stéphane Jamain, et al.
Brain, Behavior, and Immunity|November 8, 2020
Deconstructing depression and negative symptoms of schizophrenia; differential and longitudinal immune correlates, and response to minocycline treatmentCarl R Krynicki, Paola Dazzan, Carmine M Pariante, et al.
Health Technology Assessment (Winchester, England)|April 21, 2016
Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trialThomas R E Barnes, Verity C Leeson, Carol Paton, et al.
Journal of Medical Internet Research|April 10, 2026
Views of People With Psychosis About Algorithm-Based Relapse Prediction and Data Sharing: Qualitative StudyEmily Eisner, Hannah Ball, John Ainsworth, et al.
Schizophrenia (Heidelberg, Germany)|July 19, 2022
Impaired verbal memory function is related to anterior cingulate glutamate levels in schizophrenia: findings from the STRATA studyKira Griffiths, Alice Egerton, Edward Millgate, et al.
The Lancet. Psychiatry|March 1, 2025
Efficacy of clozapine versus second-generation antipsychotics in people with treatment-resistant schizophrenia: a systematic review and individual patient data meta-analysisJohannes Schneider-Thoma, Tasnim Hamza, Konstantina Chalkou, et al.
Translational Psychiatry|September 18, 2023
Network analysis of inflammation and symptoms in recent onset schizophrenia and the influence of minocycline during a clinical trialSarah E Herniman, Stephen J Wood, Golam Khandaker, et al.
JMIR Formative Research|July 7, 2026
Evaluating Wearable Devices for Remote Monitoring in Psychosis: Pilot Study Nested Within the CONNECT Cohort StudySiân Bladon, John Ainsworth, Roberto Cahuantzi, et al.
The Lancet. Psychiatry|October 17, 2018
The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trialBill Deakin, John Suckling, Thomas R E Barnes, et al.
Journal of Psychopharmacology (Oxford, England)|December 13, 2019
Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for PsychopharmacologyThomas Re Barnes, Richard Drake, Carol Paton, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Schizophrenia Bulletin|March 12, 2015
The promise of biological markers for treatment response in first-episode psychosis: a systematic reviewGuillaume Fond, Marc-Antoine d'Albis, Stéphane Jamain, et al.
Brain, Behavior, and Immunity|November 8, 2020
Deconstructing depression and negative symptoms of schizophrenia; differential and longitudinal immune correlates, and response to minocycline treatmentCarl R Krynicki, Paola Dazzan, Carmine M Pariante, et al.
Health Technology Assessment (Winchester, England)|April 21, 2016
Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trialThomas R E Barnes, Verity C Leeson, Carol Paton, et al.
Journal of Medical Internet Research|April 10, 2026
Views of People With Psychosis About Algorithm-Based Relapse Prediction and Data Sharing: Qualitative StudyEmily Eisner, Hannah Ball, John Ainsworth, et al.
Schizophrenia (Heidelberg, Germany)|July 19, 2022
Impaired verbal memory function is related to anterior cingulate glutamate levels in schizophrenia: findings from the STRATA studyKira Griffiths, Alice Egerton, Edward Millgate, et al.
The Lancet. Psychiatry|March 1, 2025
Efficacy of clozapine versus second-generation antipsychotics in people with treatment-resistant schizophrenia: a systematic review and individual patient data meta-analysisJohannes Schneider-Thoma, Tasnim Hamza, Konstantina Chalkou, et al.
Translational Psychiatry|September 18, 2023
Network analysis of inflammation and symptoms in recent onset schizophrenia and the influence of minocycline during a clinical trialSarah E Herniman, Stephen J Wood, Golam Khandaker, et al.
JMIR Formative Research|July 7, 2026
Evaluating Wearable Devices for Remote Monitoring in Psychosis: Pilot Study Nested Within the CONNECT Cohort StudySiân Bladon, John Ainsworth, Roberto Cahuantzi, et al.
The Lancet. Psychiatry|October 17, 2018
The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trialBill Deakin, John Suckling, Thomas R E Barnes, et al.
Journal of Psychopharmacology (Oxford, England)|December 13, 2019
Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for PsychopharmacologyThomas Re Barnes, Richard Drake, Carol Paton, et al.
Pageof 7